Seborrhoeic keratosis removal in a multicentre phase I/II clinical trial using a novel topical formulation (BL-5010)-Reference-Cited by-同舟云学术

Seborrhoeic keratosis removal in a multicentre phase I/II clinical trial using a novel topical formulation (BL-5010)

Published:2015-05-26 Issue:1 Volume:173 Page:247-249
ISSN:0007-0963
Container-title:British Journal of Dermatology
language:en
Short-container-title:Br J Dermatol

Author:

Levy-Nissenbaum E.¹,Thio H.B.²,Burstein P.³,Thaci D.⁴

Affiliation:

1. BioLineRx Ltd; Jerusalem Israel

2. Department of Dermatology; Erasmus Medical Center; Rotterdam the Netherlands

3. Innovative Pharmaceutical Concepts Inc.; Ramat HaSharon Israel

4. Comprehensive Center of Inflammation Medicine; University Hospital Schleswig Holstein Campus Lübeck; Lübeck Germany

Funder

Bio-LineRx Ltd

Publisher

Wiley

Subject

Dermatology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/bjd.13623/fullpdf

Reference9 articles.

1. Seborrheic keratosis;Hafner;J Dtsch Dermatol Ges,2008

2. Medium-depth chemical peeling;Otley;Semin Cutan Med Surg,1996

3. Induction of PDGF-B in TCA-treated epidermal keratinocytes;Yonei;Arch Dermatol Res,2007

4. Topical formic acid puncture technique for the treatment of common warts;Bhat;Int J Dermatol,2001

5. ASEAN Cosmetic Documents Annex VI. List of preservatives allowed for use in cosmetic products http://www.aseancosmetics.org/docdocs/Annexe_VI_%28Ref_No._Order%29_02_December_2009.pdf

Cited by 6 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Seborrhoische Keratosen;JDDG: Journal der Deutschen Dermatologischen Gesellschaft;2023-03

2. Seborrheic keratosis;JDDG: Journal der Deutschen Dermatologischen Gesellschaft;2023-03

3. Advances in the Etiology, Detection, and Clinical Management of Seborrheic Keratoses;Dermatology;2021-07-26

4. Safety and efficacy of hydrogen peroxide topical solution, 40% (w/w), in patients with seborrheic keratoses: Results from 2 identical, randomized, double-blind, placebo-controlled, phase 3 studies (A-101-SEBK-301/302);Journal of the American Academy of Dermatology;2018-11

5. A-101, a Proprietary Topical Formulation of High-Concentration Hydrogen Peroxide Solution: A Randomized, Double-Blind, Vehicle-Controlled, Parallel Group Study of the Dose–Response Profile in Subjects With Seborrheic Keratosis of the Face;Dermatologic Surgery;2018-03